BCM
VNRX icon

Bridgeway Capital Management’s VolitionRx Ltd VNRX Stock Holding History

Bridgeway Capital Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,014
Closed -$12.2K – 1257
2024
Q4 		$12.2K Sell
1,014
-195
-16% -$2.62K ﹤0.01% 1190
2024
Q3 		$14.5K Sell
1,209
-7,500
-86% -$96.5K ﹤0.01% 1248
2024
Q2 		$105K Hold
8,709
– – ﹤0.01% 1159
2024
Q1 		$132K Sell
8,709
-96
-1% -$1.88K ﹤0.01% 1175
2023
Q4 		$126K Hold
8,805
– – ﹤0.01% 1208
2023
Q3 		$121K Hold
8,805
– – ﹤0.01% 1192
2023
Q2 		$245K Hold
8,805
– – 0.01% 1089
2023
Q1 		$336K Buy
8,805
+2,500
+40% +$105K 0.01% 980
2022
Q4 		$306K Hold
6,305
– – 0.01% 985
2022
Q3 		$171K Sell
6,305
-5,750
-48% -$217K ﹤0.01% 1166
2022
Q2 		$494K Hold
12,055
– – 0.01% 879
2022
Q1 		$726K Hold
12,055
– – 0.01% 855
2021
Q4 		$757K Sell
12,055
-1,250
-9% -$85.3K 0.01% 854
2021
Q3 		$825K Sell
13,305
-1,860
-12% -$118K 0.02% 878
2021
Q2 		$998K Sell
15,165
-6,440
-30% -$436K 0.02% 858
2021
Q1 		$1.63M Buy
21,605
+13,830
+178% +$1.19M 0.03% 695
2020
Q4 		$605K Buy
7,775
+2,805
+56% +$193K 0.01% 882
2020
Q3 		$319K Hold
4,970
– – 0.01% 1040
2020
Q2 		$387K Sell
4,970
-6,250
-56% -$451K 0.01% 947
2020
Q1 		$698K Hold
11,220
– – 0.02% 655
2019
Q4 		$1.06M Hold
11,220
– – 0.01% 724
2019
Q3 		$1.26M Hold
11,220
– – 0.02% 659
2019
Q2 		$705K Hold
11,220
– – 0.01% 864
2019
Q1 		$729K Hold
11,220
– – 0.01% 877
2018
Q4 		$406K Hold
11,220
– – 0.01% 1062
2018
Q3 		$581K Buy
11,220
+1,250
+13% +$51.4K 0.01% 1099
2018
Q2 		$399K Hold
9,970
– – ﹤0.01% 1195
2018
Q1 		$479K Buy
9,970
+4,500
+82% +$263K 0.01% 1104
2017
Q4 		$322K Buy
+5,470
New +$320K ﹤0.01% 1201

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Bridgeway Capital Management's VNRX Position: Q1 2025 in Review

Bridgeway Capital Management sold out of VolitionRx Ltd (VNRX) in Q1 2025, closing a stake of 1,014 shares — an estimated $12.2K sold.

Bridgeway Capital Management first reported a position in VNRX in Q4 2017 and held it in 29 quarters. The position peaked at $1.63M in Q1 2021. 25 funds tracked by Wall St. Rank hold VNRX as of Q1 2025.

  • Bridgeway Capital Management reported no remaining VolitionRx Ltd position as of Q1 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 1,014 VolitionRx Ltd shares in Q1 2025, an estimated $12.2K.
  • Bridgeway Capital Management first reported a position in VolitionRx Ltd in Q4 2017 and held it in 29 quarters.
  • Bridgeway Capital Management's VolitionRx Ltd position peaked at $1.63M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2025.

Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.